Evidence map›Paper›PMID 33861419›Full record

ArticleDrug delivery and translational research2022

Conventional versus drug-eluting embolic transarterial chemoembolization with doxorubicin: comparative drug delivery, pharmacokinetics, and treatment response in a rabbit VX2 tumor model.

Ron C Gaba, Ramzy C Khabbaz, Ruth N Muchiri, Joseph D Morrison, Lobna Elkhadragy, William M Totura, Jonathan P Samuelson, Herbert E Whiteley, Ryan L Deaton, Peter L Nguyen and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Drug delivery and translational research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Bevacizumab-loaded CalliSpheres beads:Frontiers in oncology · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Ron C GabaDepartment of Radiology, University of Illinois at Chicago, Chicago, USA. rgaba@uic.edu.
Ramzy C KhabbazDepartment of Radiology, University of Illinois at Chicago, Chicago, USA.
Ruth N MuchiriDepartment of Pharmaceutical Sciences, Linus Pauling Institute, Oregon State University, Corvallis, USA.
Joseph D MorrisonDepartment of Neurosurgery, Rush University, Chicago, USA.
Lobna ElkhadragyDepartment of Radiology, University of Illinois at Chicago, Chicago, USA.
William M ToturaDepartment of Radiology, University of Illinois at Chicago, Chicago, USA.
Jonathan P SamuelsonCollege of Veterinary Medicine, University of Illinois at Urbana-Champaign, Champaign, USA.
Herbert E WhiteleyCollege of Veterinary Medicine, University of Illinois at Urbana-Champaign, Champaign, USA.
Ryan L DeatonResearch Histology and Tissue Imaging Core, University of Illinois at Chicago, Chicago, USA.
Peter L NguyenResearch Histology and Tissue Imaging Core, University of Illinois at Chicago, Chicago, USA.
Maria SverdlovResearch Histology and Tissue Imaging Core, University of Illinois at Chicago, Chicago, USA.
Jeremy J JohnsonDepartment of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, USA.
Richard B van BreemenDepartment of Pharmaceutical Sciences, Linus Pauling Institute, Oregon State University, Corvallis, USA.
R Peter LokkenDepartment of Radiology, University of California at San Francisco, San Francisco, USA.
University of Illinois Chicago · USOregon State University · USUniversity of Illinois Urbana-Champaign · USRush University · USUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to compare intra-tumoral drug delivery, pharmacokinetics, and treatment response after doxorubicin (DOX) conventional (c-) versus drug-eluting embolic (DEE-) transarterial chemoembolization (TACE) in a rabbit VX2 liver tumor model. Twenty-four rabbits with solitary liver tumors underwent c-TACE (n = 12) (1:2 water-in-oil emulsion, 0.6 mL volume, 2 mg DOX) or DEE-TACE (n = 12) (130,000 70-150 µm 2 mg DOX-loaded microspheres). Systemic, intra-tumoral, and liver DOX levels were measured using mass spectrometry up to 7-day post-procedure. Intra-tumoral DOX distribution was quantified using fluorescence imaging. Percent tumor necrosis was quantified by a pathologist blinded to treatment group. Lobar TACE was successfully performed in all cases. Peak concentration (C

Indexed as

Carcinoma, HepatocellularChemoembolization, TherapeuticLiver NeoplasmsAnimalsDoxorubicinNecrosisRabbitsTreatment OutcomeDoxorubicinAnimal modelDoxorubicinDrug deliveryPharmacokineticsTransarterial chemoembolization

Identifiers

PMID33861419
OpenAlexW3154088627

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.